NEUROONE MED TECHNOLOGIES CO's ticker is NMTC and the CUSIP is 64130M209. A total of 12 filers reported holding NEUROONE MED TECHNOLOGIES CO in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $44,000 | – | 53,403 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mayo Clinic | 181,754 | $161,834 | 0.31% |
| PERKINS CAPITAL MANAGEMENT INC | 150,000 | $134 | 0.13% |
| Nantahala Capital Management | 1,250,000 | $1,113,000 | 0.10% |
| Princeton Global Asset Management LLC | 16,833 | $14,988 | 0.00% |
| MAI Capital Management | 50,000 | $44,520 | 0.00% |
| SG Americas Securities, LLC | 50,453 | $45 | 0.00% |
| Walleye Capital LLC | 225,956 | $201,191 | 0.00% |
| UBS Group AG | 108 | $96 | 0.00% |
| NewEdge Advisors, LLC | 2,380 | $2,119 | 0.00% |
| OSAIC HOLDINGS, INC. | 700 | $623 | 0.00% |